Medipal Holdings Corporation (7459) on Oct. 23 raised its forecast for full-year net profit attributable to owners of the parent for the fiscal year ending March 2027 to ¥53.0 billion from ¥43.0 billion, up 23.3%, and announced it would buy back up to ¥10 billion of its own shares and cancel them.
The company attributed the revision mainly to gains from reducing its strategic shareholdings. Between May and October 2026, it sold holdings in eight listed companies, generating a gain on sales of investment securities of ¥15.49 billion, booked as extraordinary income. Of that, ¥6.06 billion was already recorded in the first quarter of the current fiscal year.
The sales were carried out in line with the Corporate Governance Code and a policy on management conscious of cost of capital and stock price that the company disclosed on May 13, 2025.
Forecasts for net sales, operating profit and ordinary profit for the year ending March 31, 2027, were left unchanged from those announced on July 14. The earnings per share forecast was raised to ¥258.92 from ¥210.06.
| Item (¥ million) | Previous forecast | Revised forecast | FY to March 2026 (actual) |
|---|---|---|---|
| Net sales | 3,944,000 | 3,944,000 | 3,817,354 |
| Operating profit | 53,500 | 53,500 | 53,182 |
| Ordinary profit | 67,500 | 67,500 | 75,723 |
| Net profit attributable to owners of parent | 43,000 | 53,000 | 42,534 |
| EPS (¥) | 210.06 | 258.92 | 206.67 |
The buyback covers up to 4 million shares, or 2.0% of shares outstanding excluding treasury stock, through market purchases on the Tokyo Stock Exchange. Medipal said it would use proceeds from the securities sales, among other funds, to improve capital efficiency and enhance shareholder returns. All repurchased shares will be cancelled. As of Sept. 30, 2026, the company had 204,698,231 shares outstanding excluding treasury stock and held 11,276,811 treasury shares.
What's next: Shares will be repurchased from Nov. 6, 2026, to March 31, 2027. Cancellation will follow the end of the repurchase, by March 31, 2027.
| Hikari Tsushin, Inc. | |
| Offer price | ¥1,000 per common share |
| M&A / TOB | 1 |
| Guidance | 0 |
| Buybacks | 0 |
| Dividends | 0 |
| Capital | 0 |
| Earnings | 0 |
| People | 0 |
Summaries of public disclosures by Japanese listed companies. Not investment advice; accuracy not guaranteed. Figures and dates in the TDnet originals prevail.
本站內容為日本上市公司公開開示之摘要整理,非投資建議,亦不保證正確。數字與日程以 TDnet 原文為準。
本サイトは日本の上場企業の適時開示を要約したものであり、投資助言ではありません。正確性は保証しません。数値・日程は TDnet の原文が優先します。